Company: XERI
Filing Date: 2025-11-12
Form Type: 8-K
Source: 0001477932-25-008111
Chunk: 0

Company: XERIANT, INC.
Filing Date: 2025-11-12
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry Into Material Definitive Agreements

On November 5. 2025, Xeriant, Inc. (the “ Company”) and Auctus Fund, LLC (“ Auctus”) entered into a Settlement Agreement (the “ Settlement Agreement”) relating to that certain Senior Secured Promissory Note dated October 27, 2021 (as amended, the “ Note”). The effective date of the Settlement Agreement is retroactive to October 29, 2025. The Settlement Agreement provides, inter alia, the following:

1. The Company will issue to Auctus 30,000,000 unrestricted shares of the Company’s Common Stock (the “ Conversion Shares”) pursuant to an existing Notice of Conversion dated February 24, 2025.

2. The Company will pay to Auctus $3,500,000 as follows: (A) $1,000,000 on or before 75 days from October 29, 2025; (B) $1,000,000 on or before 105 days from October 29, 2025;(C) $1,000,000 on or before 135 days from October 29, 2025; and (D) $500,000 on or before 165 days from October 29, 2025.

3. Within ten (10) business days of receipt by the Company of any money or any other consideration pertaining to the legal action brought by the Company against XTI Aircraft Company, the Company will transfer litigation proceeds to Auctus on a preferred basis and share on a percentage basis thereafter net of legal fees not to exceed $250,000.

4. Provided that the Company timely makes all payments with respect to the $3,500,000, Auctus will return to Company (a) a Warrant dated July 26, 2022 to purchase 25,000,000 shares of the Company’s Common Stock and (b) a Warrant dated December 27, 2022 to purchase 25,000,000 shares of the Company’s Common Stock.

5. So long as the Company makes all payments as set forth above, Auctus will suspend any further exercise of its conversion rights under the Note.

6. The Company has issued a full and unconditional release to Auctus regarding any claims that the Company has against Auctus with respect to the Note and all agreements relating to the Note.

7. The Company agrees that it will not pursue